Soaring Demand Set to Propel Women's Health Market to $57.59 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Women's Health Market Through 2025?
The valuation of the women's health sector has experienced consistent upward movement over the past few years, projected to ascend from $43.53 billion in 2024 to $45.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.2%. This expansion witnessed during the historical timeframe is traceable to several key factors, including progress in reproductive medical science, heightened public awareness and educational campaigns, strengthening empowerment and advocacy efforts, improvements in care before and after childbirth, and the creation of new hormone replacement treatments.

What's the Projected Size of the Global Women's Health Market by 2029?
Anticipation is for significant expansion within the women's health sector over the coming years, projecting a market valuation of $57.59 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.2%; this upward trajectory during the projection window is underpinned by advancements such as the deployment of precision medicine techniques in gynecology, an increase in clinical studies concentrating on female health, broader application of non-invasive prenatal screening methods, enhanced availability of fertility interventions, and a heightened emphasis on psychological well-being. Concerning dominant currents shaping the market through the forecast timeframe, these encompass the adoption of digital wellness platforms, developments in tracking fertility and overall reproductive wellness, the emergence of birth control alternatives that do not rely on hormones, continuous monitoring for maternal health and pregnancy status, novel developments in diagnostic tools for women's health issues, and the incorporation of artificial intelligence capabilities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Top Growth Drivers in the Women's Health Industry: What's Accelerating the Market?
The increasing incidence of health conditions specifically affecting women is projected to fuel the expansion of the women's health sector in the foreseeable future. Conditions such as anemia, osteoporosis, breast cancer, and menopause, among others, are frequently observed in women, often attributed to multiple risk elements including genetic predisposition, advancing age, experiencing prematurely or a later menopause onset past 55, and excessive body weight. This heightened occurrence of female-specific ailments consequently boosts the need for both products and professional services targeting women's health, which are essential for managing these illnesses and maintaining female well-being. To illustrate, the American Cancer Society, a US-based non-profit organization focused on cancer eradication, reported in an article in January 2023 that cervical cancer used to rank among the leading causes of cancer mortality for women in America. Projections for 2023 indicated that approximately 13,960 new instances of invasive cervical cancer would be identified across the USA, with an estimated 4,310 women succumbing to the disease that same year, thereby demonstrating how the escalating rates of women-centric medical issues stimulate the growth trajectory of the women's health market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

What Trends Will Shape the Women's Health Market Through 2029 and Beyond?
Advancements within the sector focused on female well-being constitute a significant movement in the women's health market landscape. Leading corporations active in this field are engaged in creating novel offerings as a means to solidify their standing. Specifically, in the month of July in 2022, GE Healthcare, a firm situated in the United States specializing in medical technology, introduced the Voluson Expert 22 system. This newest enhancement to their suite of products addressing women's health utilizes technology based on graphic beam forming, resulting in image clarity that is better and offers greater adaptability in how imaging tasks are performed. Incorporating state-of-the-art instruments driven by Artificial Intelligence, this apparatus guarantees improved uniformity across examinations while simultaneously decreasing the volume of necessary procedures.

What Are the Main Segments in the Women's Health Market?
The women's healthmarket covered in this report is segmented -

1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline
2) By Age: 50 Years & above ; Other Ages
3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries
4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic ovary* Syndrome (PCOS)
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:
1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps
2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives
3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8017&type=smp

Which Top Companies are Driving Growth in the Women's Health Market?
Major companies operating in the women's health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG

Which Regions Will Dominate the Women's Health Market Through 2029?
North America was the largest region in the women's health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8017

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.